Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies.

By Anke Göbel, Christa S. McArdell, A. Joss, H. Siegrist, W. Giger. Science of the Total Environment, 2007

776 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/26142df15aafc427e559116ef047b1b327e0b95f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. (2009, background): “Göbel et al. (2007) reported the following percentage removal of three antibiotics during conventional activated sludge treatment: sulfamethoxazole, 138 to 60%; trimethoprim, 40 to 20% and erythromycin-H2O, 22 to 6%.”
Fate of antibiotics during municipal water recycling treatment processes. (2010, methodology): “In Switzerland, clarithromycin is more often detected inWWTPs effluents at higher concentrations than erythromycin-H2O and roxythromycin, which is well correlated to consumption data (Gobel et al., 2007).”
Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon? (2013, result): “Similar observations in other studies were attributed to (i) release during the treatment of compounds trapped in faeces particles (Göbel et al., 2007), (ii) biological cleavage in the treatment of pharmaceutical conjugates (human metabolites) producing again the parent compound (Onesios et al.”
Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. (2007, background): “The fates of sulfonamides, macrolides and trimethoprim were investigated in different wastewater treatment technologies in Switzerland (Göbel et al., 2007).”
From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review. (2017, background): “Gobel et al. (2007) demonstrated that the combination of a high SRT with reduced F/M ratios may induce an increased biodiversity, and thus enhance elimination of compounds such as TMP, and CLA by co-metabolism processes.”
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review. (2012, background): “As to the two sulphonamides sulfamethoxazole and sulfasalazine, theirmainmetabolites entering the sewage are biologically inactive N4-acetylated products and may retransform back to the initial parent compound (Göbel et al., 2007).”
Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. (2010, background): “While Göbel and coworkers (Göbel et al., 2007) observed higher concentrations of several antibiotics (some sulphonamides, macrolides and trimethoprim) in effluent samples, the anti-epileptic carbamazepine followed”
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. (2014, background): “Redox conditions may cause the observed differences by having an effect on certain wastewater or sludge characteristics as wells as on the biodiversity of the microbial flora present (Göbel et al., 2007).”
Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. (2013, background): “Erythromycin-H2O was degraded by 15% and 26% in activated sludge processes at Shatin and Stanley UWTP, respectively (Li and Zhang, 2011), and up to 10% in two Swiss UWTPs (Göbel et al., 2007).”
Degradation and removal methods of antibiotics from aqueous matrices--a review. (2011, methodology): “Most conventional treatments applied in WWTPs and DWTPs (such as coagulation, flocculation, sedimentation and filtration) were unsuccessful in the removal of these compounds (Vieno et al., 2007; Adams et al., 2002; Göbel et al., 2007), requiring the development of new efficient methodologies.”